Dean F. Bajorin

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 2%percentile

2.7Author DataRank

Indexed papers

4in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 4 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Clinical and Genomic Landscape of FGFR3-Altered Urothelial Carcinoma and Treatment Outcomes with Erdafitinib: A Real-World Experience

Clinical Cancer Research(2023)10.1158/1078-0432.ccr-23-1283

Top 12%

1.8DataRank

Top 12%68 citations

Michal Sarfaty, Min Yuen Teo, Neha Ratna, Cihan Düzgöl, Samuel A. Funt +18 more

Papers

Driven by 46 papers — median percentile 75. Top paper: “Adjuvant Nivolumab versus Placebo in Muscle-Invasive Urothelial Carcinoma”.

Adjuvant Nivolumab versus Placebo in Muscle-Invasive Urothelial Carcinoma

New England Journal of Medicine(2021)10.1056/nejmoa2034442

N/A

7.0DataRank · unranked

1043 citations

J. Alfred Witjes, Jürgen E. Gschwend, Michael Schenker, Begoña P. Valderrama, Yoshihiko Tomita +24 more

Long-Term Outcomes in KEYNOTE-052: Phase II Study Investigating First-Line Pembrolizumab in Cisplatin-Ineligible Patients With Locally Advanced or Metastatic Urothelial Cancer

Journal of Clinical Oncology(2020)10.1200/jco.19.01213

N/A

4.9DataRank · unranked

294 citations

Arjun Vasant Balar, Daniel Castellano, Peter H. O’Donnell, Petros Grivas, Joaquim Bellmunt +11 more

Neoadjuvant Atezolizumab With Gemcitabine and Cisplatin in Patients With Muscle-Invasive Bladder Cancer: A Multicenter, Single-Arm, Phase II Trial

Journal of Clinical Oncology(2022)10.1200/jco.21.01485

N/A

3.3DataRank · unranked

100 citations

Michael Lattanzi, Karissa Whiting, Hikmat Al‐Ahmadie, Colleen Quinlan, Min Yuen Teo +34 more

Neoantigen-specific CD8 T cell responses in the peripheral blood following PD-L1 blockade might predict therapy outcome in metastatic urothelial carcinoma

Nature Communications(2022)10.1038/s41467-022-29342-0

N/A

2.1DataRank · unranked

82 citations

Samuel A. Funt, Annie Borch, Kamilla Kjærgaard Munk, Anne-Mette Bjerregaard, James L. Reading +17 more

Clinical and Genomic Landscape of FGFR3-Altered Urothelial Carcinoma and Treatment Outcomes with Erdafitinib: A Real-World Experience

Clinical Cancer Research(2023)10.1158/1078-0432.ccr-23-1283

Top 12%

1.8DataRank

Top 12%68 citations

Michal Sarfaty, Min Yuen Teo, Neha Ratna, Cihan Düzgöl, Samuel A. Funt +18 more

Natural history, response to systemic therapy, and genomic landscape of plasmacytoid urothelial carcinoma

British Journal of Cancer(2021)10.1038/s41416-020-01244-2

N/A

1.6DataRank · unranked

40 citations

Hikmat Al‐Ahmadie, Kenneth Seier, Christopher Tully, Ashley Marie Regazzi, Eugene J. Pietzak +15 more

Cancer therapy shapes the fitness landscape of clonal hematopoiesis

Nature Genetics(2020)10.1038/s41588-020-00710-0

N/A

0.993DataRank · unranked

750 citations

Ryan Ptashkin, Teng Gao, Lior Z. Braunstein, Sean M. Devlin, Daniel J. Kelly +59 more

Pathological and oncological outcomes in patients with sarcomatoid differentiation undergoing cystectomy

British Journal of Urology(2021)10.1111/bju.15428

N/A

0.951DataRank · unranked

25 citations

Emily Vertosick, Daniel D. Sjoberg, Nathan C. Wong, Chun Huang, Eugene J. Pietzak +10 more

Long-term Outcomes of Local and Metastatic Small Cell Carcinoma of the Urinary Bladder and Genomic Analysis of Patients Treated With Neoadjuvant Chemotherapy

Clinical Genitourinary Cancer(2022)10.1016/j.clgc.2022.05.005

N/A

0.937DataRank · unranked

33 citations

Brendan J. Guercio, Arshi Arora, Xueli Hao, Ashley Marie Regazzi, Timothy F. Donahue +25 more

Germ Cell Tumor Molecular Heterogeneity Revealed Through Analysis of Primary and Metastasis Pairs

JCO Precision Oncology(2020)10.1200/po.20.00166

Top 25%

0.821DataRank

Top 25%17 citations

Mark T.A. Donoghue, François Audenet, Nathan C. Wong, Eugene J. Pietzak, Craig M. Bielski +25 more

Final Results of a Phase I Trial of WST-11 (TOOKAD Soluble) Vascular-targeted Photodynamic Therapy for Upper Tract Urothelial Carcinoma

The Journal of Urology(2023)10.1097/ju.0000000000003202

N/A

0.740DataRank · unranked

26 citations

Daniel D. Sjoberg, Lucas Nogueira, Andrew Tracey, Ricardo Alvim, Peter A. Reisz +16 more

Fundamental immune–oncogenicity trade-offs define driver mutation fitness

Nature(2022)10.1038/s41586-022-04696-z

N/A

0.663DataRank · unranked

82 citations

Roberta Zappasodi, Isabell Schulze, Zachary Sethna, Kelvin C. de Andrade, Dean F. Bajorin +25 more

PD-1 directed immunotherapy alters Tfh and humoral immune responses to seasonal influenza vaccine

Nature Immunology(2022)10.1038/s41590-022-01274-3

N/A

0.663DataRank · unranked

82 citations

David A. Knorr, Laura A. Vella, Luisa Victoria Silva, Lakshmi Chilukuri, Sokratis A. Apostolidis +23 more

Genome-wide Association Study of Bladder Cancer Reveals New Biological and Translational Insights

European Urology(2023)10.1016/j.eururo.2023.04.020

N/A

0.650DataRank · unranked

75 citations

Lambertus A. Kiemeney, Parichoy Pal Choudhury, Roger L. Milne, Evangelina López de Maturana, Yuanqing Ye +95 more

Genomic heterogeneity as a barrier to precision oncology in urothelial cancer

Cell Reports(2022)10.1016/j.celrep.2022.111859

N/A

0.648DataRank · unranked

74 citations

Ziyu Chen, Hannah Wise, Andrew T. Lenis, Shweta S. Chavan, Mark T.A. Donoghue +20 more

Differential NEUROD1, ASCL1, and POU2F3 Expression Defines Molecular Subsets of Bladder Small Cell/Neuroendocrine Carcinoma With Prognostic Implications

Modern Pathology(2024)10.1016/j.modpat.2024.100557

N/A

0.646DataRank · unranked

18 citations

Karissa Whiting, Min-Yuen Teo, Jacob E. Tallman, Gamze Gokturk Ozcan, Merve Başar +21 more

Tumor fraction-guided cell-free DNA profiling in metastatic solid tumor patients

Genome Medicine(2021)10.1186/s13073-021-00898-8

N/A

0.614DataRank · unranked

59 citations

Michael L. Cheng, Maha Shady, Julie L. Yang, Dennis Stephens, Helen Won +32 more

Putative Biomarkers of Clinical Benefit With Pembrolizumab in Advanced Urothelial Cancer: Results from the KEYNOTE-045 and KEYNOTE-052 Landmark Trials

Clinical Cancer Research(2022)10.1158/1078-0432.ccr-21-3089

N/A

0.587DataRank · unranked

49 citations

Ronald de Wit, Yves Fradet, Miguel A. Climent, Daniel P. Petrylak, Jae‐Lyun Lee +26 more

Targeting Germline- and Tumor-Associated Nucleotide Excision Repair Defects in Cancer

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-20-3322

N/A

0.574DataRank · unranked

45 citations

Zoe Steinsnyder, Vignesh Ravichandran, Kaitlyn Tkachuk, Yelena Kemel, Chaitanya Bandlamudi +16 more

Paclitaxel, Ifosfamide, and Cisplatin as Initial Salvage Chemotherapy for Germ Cell Tumors: Long-Term Follow-Up and Outcomes for Favorable- and Unfavorable-Risk Disease

Journal of Clinical Oncology(2024)10.1200/jco.23.02542

N/A

0.556DataRank · unranked

14 citations

Andrea Knežević, Maria Bromberg, Sujata Patil, Joel Sheinfeld, Brett S. Carver +9 more

Atezolizumab monotherapy for metastatic urothelial carcinoma: final analysis from the phase II IMvigor210 trial

ESMO Open(2024)10.1016/j.esmoop.2024.103972

N/A

0.515DataRank · unranked

30 citations

M.D. Galsky, Thomas Powles, Daniel P. Petrylak, Joaquim Bellmunt, Y. Loriot +19 more

Clinical Outcomes, Genomic Heterogeneity, and Therapeutic Considerations Across Histologic Subtypes of Urothelial Carcinoma

European Urology(2025)10.1016/j.eururo.2025.04.008

N/A

0.489DataRank · unranked

25 citations

Ziyu Chen, Karissa Whiting, Irina Ostrovnaya, Andrew T. Lenis, Timothy N. Clinton +26 more

Inherited Germline Cancer Susceptibility Gene Variants in Individuals with Non–Muscle-Invasive Bladder Cancer

Clinical Cancer Research(2022)10.1158/1078-0432.ccr-22-1006

N/A

0.416DataRank · unranked

15 citations

Karissa Whiting, Preethi Srinivasan, Chaitanya Bandlamudi, Aliya Khurram, Vijai Joseph +26 more

Neoadjuvant Chemotherapy for High-risk Localized Upper Tract Urothelial Carcinoma: Final Long-term Outcomes from a Phase 2 Clinical Trial and an Expanded Cohort

European Urology(2025)10.1016/j.eururo.2025.08.012

N/A

0.357DataRank · unranked

9 citations

Melissa Assel, Gopa Iyer, Scot A. Niglio, Bernard H. Bochner, Guido Dalbagni +28 more

Final results of a multicenter prospective phase II clinical trial of gemcitabine and cisplatin as neoadjuvant chemotherapy in patients with high-grade upper tract urothelial carcinoma.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.6_suppl.440

N/A

0.312DataRank · unranked

7 citations

Jonathan Coleman, Nathan C. Wong, Daniel D. Sjoberg, Bernard H. Bochner, Guido Dalbagni +15 more

Natural History and Genomic Landscape of Chemotherapy-Resistant Muscle-Invasive Bladder Cancer

JCO Precision Oncology(2024)10.1200/po.23.00274

N/A

0.292DataRank · unranked

6 citations

Karissa Whiting, Vignesh Ravichandran, Jacob E. Tallman, Syed M. Alam, Carissa Chu +29 more

Large cell neuroendocrine carcinoma of the urothelial tract (LNEC): The MSKCC experience.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.4526

N/A

0.269DataRank · unranked

5 citations

Jatin Gandhi, Min Yuen Teo, Michael Lattanzi, Samuel A. Funt, David H. Aggen +14 more

Defining germline genetics of germ cell tumor: Implications for genetic testing and clinical management.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.5007

N/A

0.241DataRank · unranked

4 citations

Vignesh Ravichandran, Yelena Kemel, Andrea Knežević, Jack P. Gleeson, Nicole Benfante +12 more

Circulating Tumor DNA and Response to Cisplatin-based Chemotherapy in Patients with Metastatic Urothelial Carcinoma Enrolled in CALGB 90601 (Alliance)

European Urology Open Science(2025)10.1016/j.euros.2025.03.009

N/A

0.208DataRank · unranked

3 citations

Karissa Whiting, Ronak Shah, Karla V. Ballman, Susan Halabi, Ashley Marie Regazzi +10 more

Associations of diet with survival of patients (pts) with metastatic cancer of the urothelium (mUC) and renal cell carcinoma (mRCC) on immune checkpoint blockade (ICB).

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.4598

N/A

0.165DataRank · unranked

2 citations

Neha Ratna, David Gavrilov, Cihan Düzgöl, Mahnoor Akhlaq, Min Yuen Teo +15 more

Defining hereditary upper tract urothelial carcinoma: Implications for genetic testing and clinical management.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.6_suppl.523

N/A

0.165DataRank · unranked

2 citations

Rania Sheikh, Yelena Kemel, Manuel De Jesus Escano, Aliya Khurram, Peter A. Reisz +15 more

Biomarkers of response to neoadjuvant atezolizumab with gemcitabine and cisplatin in muscle-invasive bladder cancer.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.4584

N/A

0.165DataRank · unranked

2 citations

Alexander Solovyov, Jayon Lihm, Colleen Quinlan, Karissa Whiting, Hao Li +15 more

Trends in management and outcomes in patients with upper tract urothelial carcinoma following radical nephrouretectomy at Memorial Sloan Kettering Cancer Center.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.6_suppl.469

N/A

0.165DataRank · unranked

2 citations

Melissa Assel, Andrew Tracey, Ricardo Alvim, Nima Almassi, Nirmish Singla +6 more

Data from Inherited Germline Cancer Susceptibility Gene Variants in Individuals with Non–Muscle-Invasive Bladder Cancer

(2023)10.1158/1078-0432.c.6532764

N/A

0DataRank · unranked

0 citations

Karissa Whiting, Preethi Srinivasan, Chaitanya Bandlamudi, Aliya Khurram, Vijai Joseph +26 more

Data from Inherited Germline Cancer Susceptibility Gene Variants in Individuals with Non–Muscle-Invasive Bladder Cancer

(2023)10.1158/1078-0432.c.6532764.v1

N/A

0DataRank · unranked

0 citations

Karissa Whiting, Preethi Srinivasan, Chaitanya Bandlamudi, Aliya Khurram, Vijai Joseph +26 more

Data from Targeting Germline- and Tumor-Associated Nucleotide Excision Repair Defects in Cancer

(2023)10.1158/1078-0432.c.6531197

Top 100%

0DataRank

Top 100%0 citations

Zoe Steinsnyder, Vignesh Ravichandran, Kaitlyn Tkachuk, Yelena Kemel, Chaitanya Bandlamudi +16 more

Detection of FGFR3 alt in plasma cfDNA in metastatic UC patients receiving Erda therapy.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.e16519

N/A

0DataRank · unranked

0 citations

Min Yuen Teo, Samuel A. Funt, Chung‐Han Lee, David H. Aggen, Neha Ratna +11 more

Neoadjuvant Gemcitabine-Cisplatin Plus Radical Cystectomy-Pelvic Lymph Node Dissection for Muscle-invasive Bladder Cancer: A 12-year Experience

Clinical Genitourinary Cancer(2020)10.1016/j.clgc.2020.02.014

N/A

0DataRank · unranked

46 citations

Christopher Tully, Emily C. Zabor, Bernard H. Bochner, Guido Dalbagni, Harry W. Herr +8 more

Detailed evaluation of hearing loss (HL) associated with high-dose (HD) carboplatin for salvage treatment of germ cell tumors (GCT).

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.6_suppl.401

N/A

0DataRank · unranked

1 citations

Andrea Knežević, Kaamilah Wilson, Maria Bromberg, Amy Budnick, Deaglan Joseph McHugh +7 more

Phase I Study of Everolimus in Combination with Gemcitabine and Split-Dose Cisplatin in Advanced Urothelial Carcinoma

UNC Libraries(2024)10.17615/6gs3-hm85

N/A

0DataRank · unranked

0 citations

Irina Ostrovnaya, Matthew I. Milowsky, Jonathan E. Rosenberg, Wassim Abida, Dean F. Bajorin +6 more

Identifying germline genetic alterations or environmental factors associated with bilateral germ cell tumor (GCT).

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.5035

N/A

0DataRank · unranked

0 citations

Emily Harrold, Maria Bromberg, Zalak Patel, Andrea Knežević, Tinu Thomas +13 more

Neoadjuvant nivolumab (N) +/- ipilimumab (I) in cisplatin-ineligible patients (pts) with muscle-invasive bladder cancer (MIBC).

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.6_suppl.498

N/A

0DataRank · unranked

12 citations

Eugene J. Pietzak, Samantha Brown, Jie‐Fu Chen, Vanessa Peters, Ashley Marie Regazzi +15 more

Oncologic outcomes of retroperitoneal lymph node dissection following first-line chemotherapy for metastatic non-seminomatous germ-cell tumors

Annals of Oncology(2025)10.1016/j.annonc.2025.03.002

N/A

0DataRank · unranked

7 citations

Fady Baky, Nicole Liso, B.M. Williams, Sanjay Porwal, Melissa Assel +13 more

Radiographic predictors of pathologic response to neoadjuvant chemotherapy with gemcitabine and cisplatin in patients with high-grade upper tract urothelial carcinoma.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.6_suppl.522

N/A

0DataRank · unranked

0 citations

Soleen Ghafoor, Hebert Alberto Vargas, Dean F. Bajorin, Jonathan Coleman, Nathan C. Wong

Re-analysis of intravesical gemcitabine in the era of Bacillus Calmette-Guérin (BCG)-unresponsive non–muscle-invasive bladder cancer

Urologic Oncology Seminars and Original Investigations(2025)10.1016/j.urolonc.2025.04.006

N/A

0DataRank · unranked

3 citations

Emily Vertosick, Neeta D’Souza, Nicole Benfante, Andrew T. Lenis, Peter A. Reisz +14 more

Genitourinary Medical Oncology Expert Opinion Survey Regarding Treatment Management in the COVID-19 Pandemic

Clinical Genitourinary Cancer(2021)10.1016/j.clgc.2020.12.002

N/A

0DataRank · unranked

2 citations

Darren R. Feldman, Michael J. Morris, Robert J. Motzer, Dana E. Rathkopf, Ashley Marie Regazzi +5 more

Dean F. Bajorin

Indexed papers

Top data-sharing exemplar

Papers